Log in to save to my catalogue

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiot...

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiot...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8500268

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

About this item

Full title

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Infection, 2022-04, Vol.50 (2), p.423-436

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
Reported antibiotic use in coronavirus disease 2019 (COVID-19) is far higher than the actual rate of reported bacterial co- and superinfection. A better understanding of antibiotic therapy in COVID-19 is necessary.
Methods
6457 SARS-CoV-2-infected cases, documented from March 18, 2020, until February 16, 2021, in the LEOSS cohort w...

Alternative Titles

Full title

All-cause mortality and disease progression in SARS-CoV-2-infected patients with or without antibiotic therapy: an analysis of the LEOSS cohort

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8500268

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8500268

Other Identifiers

ISSN

0300-8126,1439-0973

E-ISSN

1439-0973

DOI

10.1007/s15010-021-01699-2

How to access this item